FDA approves Abiomed's Impella RP

Abiomed wins a humanitarian device exemption for its Impella RP

Abiomed (NSDQ:ABMD) today said the FDA approved a humanitarian device exemption for its Impella RP heart pump, calling the device the 1st FDA-approved percutaneous, single-access pump for supporting the heart's right ventricle.

Food & Drug Administration (FDA), Abiomed Inc.

News Well, Humanitarian Device Exemption (HDE), Cardiac Assist Devices

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zsEJ6w